EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l ‐amino acid‐based product

Abrar Turki, Sylvia Stockler-Ipsiroglu, Sandra Sirrs, Jennifer Branov, Taryn Bosdet, Rajavel Elango iD

Journal of Inherited Metabolic Disease · 2025-01 · 48 (1)

DOI: 10.1002/jimd.12806 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 15.10.2024. Verfasst von Abrar Turki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Nutrition Department, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin, Eastern Province, Saudi Arabia. Hauptthemen laut MEDLINE: Phenylketonurias, Biological Availability, Amino Acids, Caseins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vitaflo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phenylketonuria (PKU) is caused by phenylalanine hydroxylase deficiency. Treatment is primarily a low‐Phe diet combined with l ‐amino acid‐based products ( l ‐AA). Protein requirements in adults with PKU have not been directly determined. A formula with glycomacropeptide (GMP) and low phenylalanine is available, yet untested for optimal protein synthesis.

Objectives

To determine the protein requirements in adults with PKU and the bioavailability of GMP‐AA in the same patients using the indicator amino acid oxidation (IAAO) technique.

Methods

Each participant was allocated to 7 separate l ‐AA intakes (range: 0.1–1.8 g/kg/day) in Experiment 1. In Experiment 2, the same patients participated in 4 GMP‐AA intakes (range: 0.1–0.9 g/kg/day). The IAAO method with l ‐[1‐ 13 C]‐lysine as the indicator amino acid and its oxidation to 13 CO 2 was used as the primary indicator of protein synthesis. Protein requirements were identified with a breakpoint, and bioavailability was determined by comparing 13 CO 2 slope from GMP‐AA versus l ‐AA.

Results

Six adults with PKU (4 M: 2F) completed a total of 54 study days over the 2 experiments. The estimated average requirement (EAR) for protein was determined to be 1.11 g/kg/day ( R 2 = 0.20). The bioavailability of protein from GMP‐AA was determined to be 99.98%, which was high and near to 100% comparable to l ‐AA; although, the results apply only to the tested GMP‐AA blend.

Conclusions

To our knowledge, this is the first study to directly define a quantitative protein requirement and indicates that current PKU protein recommendations for adults with PKU may be underestimated. The bioavailability of protein in the GMP‐AA blend was high and optimal for protein synthesis in adults with PKU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylketonuriasBiological AvailabilityAmino AcidsCaseinsHumansAdultMaleFemaleYoung AdultPhenylalaninePeptide FragmentsMiddle AgedNutritional RequirementsDietary ProteinsAdolescent

Stichwörter der Autor:innen

IAAO techniquePKU adultsglycomacropeptidephenylketonuriaprotein bioavailabilityprotein requirements

Substanzen

Amino AcidsCaseinsPhenylalaninecaseinomacropeptidePeptide FragmentsDietary Proteins

Autor:innen und Institutionen

  • Clinical Nutrition Department, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin, Eastern Province, Saudi Arabia.
  • BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Biochemical Genetics, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Department of Medicine, Division of Endocrinology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Vancouver Costal Health, Adult Metabolic Diseases Clinic, Vancouver, British Columbia, Canada.

ORCID-Profile: Rajavel Elango

Förderung

  • Vitaflo

Zitieren

APA

Turki, A., Stockler-Ipsiroglu, S., Sirrs, S., Branov, J., Bosdet, T., & Elango, R. (2025). Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l ‐amino acid‐based product. Journal of Inherited Metabolic Disease, 48(1). https://doi.org/10.1002/jimd.12806

Vancouver

Turki A, Stockler-Ipsiroglu S, Sirrs S, Branov J, Bosdet T, Elango R. Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l ‐amino acid‐based product. Journal of Inherited Metabolic Disease. 2025;48(1). doi:10.1002/jimd.12806

BibTeX
@article{Turki2025,
  author = {Turki, Abrar and Stockler-Ipsiroglu, Sylvia and Sirrs, Sandra and Branov, Jennifer and Bosdet, Taryn and Elango, Rajavel},
  title = {Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l ‐amino acid‐based product},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  volume = {48},
  number = {1},
  doi = {10.1002/jimd.12806}
}
Kostenlos starten →